Hofseth BioCare ASA (OSTO:HBCO) LT-Debt-to-Total-Asset : 0.25 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Hofseth BioCare ASA LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Hofseth BioCare ASA's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.25.

Hofseth BioCare ASA's long-term debt to total assets ratio increased from Mar. 2023 (0.23) to Mar. 2024 (0.25). It may suggest that Hofseth BioCare ASA is progressively becoming more dependent on debt to grow their business.

Hofseth BioCare ASA LT-Debt-to-Total-Asset Historical Data

The historical data trend for Hofseth BioCare ASA's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hofseth BioCare ASA LT-Debt-to-Total-Asset Chart

Hofseth BioCare ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.35

0.19

0.30

0.22

0.25

Hofseth BioCare ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.23	0.22	0.22	0.25	0.25

Hofseth BioCare ASA LT-Debt-to-Total-Asset Calculation

Hofseth BioCare ASA's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	97.102	/	390.119
	=	0.25

Hofseth BioCare ASA's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	95.689	/	390.714
	=	0.24

Hofseth BioCare ASA (OSTO:HBCO) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Hofseth BioCare ASA LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Hofseth BioCare ASA's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Hofseth BioCare ASA (OSTO:HBCO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hofseth BioCare ASA (OSTO:HBCO) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

HOFBF:USA HBC:Norway HBQ:Germany

Address

Kipervikgata 13, Aalesund, NOR, 6003

Website

https://www.hofsethbiocare.com

Hofseth BioCare ASA is a Norway based company engaged in the business of development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. It is also involved in cooperation, participation, and ownership in the businesses engaged in related activities. The group operates in the business segment of producing salmon oil, soluble protein, calcium, and nonwater soluble protein. The brands under the company are OmeGo, PetGo, ProGo, and CalGo. The firm sells products to various segments of the human nutrition market such as sports nutrition, supplements, and health foods, as well as to the market within nutrition to pet and feed industry. It generates the majority of the revenue from the sale of salmon oil internationally.

Hofseth BioCare ASA (OSTO:HBCO) Headlines

No Headlines